FDA looks again at Boston Scientific anti-stroke device

(Reuters) - U.S. Food and Drug Administration staff reviewing data on Boston Scientific Corp's novel anti-stroke device highlighted the implant's failure to meet a key goal for effectiveness in a recent study but said on Monday that other data must be weighed in deciding whether it should be approved.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news